Lessons From Risk Minimization FCA Cases Post-Escobar
In recent years, plaintiffs in False Claims Act, 31 U.S.C. § 3729 et seq. (2006), cases have sought to expand FCA liability of pharmaceutical and medical device companies alleging that these...To view the full article, register now.
Already a subscriber? Click here to view full article